These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 35475361

  • 21. Clinical psychopharmacology and inpatient psychiatry: the revolution, its achievements and its dangers.
    Alarcon RD, Walter-Ryan WG.
    Psychiatr Med; 1986; 4(4):387-406. PubMed ID: 2893433
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
    Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, Hough D, Drevets WC, Singh JB.
    Int J Neuropsychopharmacol; 2019 Oct 01; 22(10):616-630. PubMed ID: 31290965
    [Abstract] [Full Text] [Related]

  • 23. A systematic review of augmentation strategies for patients with major depressive disorder.
    Fleurence R, Williamson R, Jing Y, Kim E, Tran QV, Pikalov AS, Thase ME.
    Psychopharmacol Bull; 2009 Oct 01; 42(3):57-90. PubMed ID: 19752841
    [Abstract] [Full Text] [Related]

  • 24. [Antidepressive agents in the elderly].
    de Hooge JK.
    Tijdschr Gerontol Geriatr; 1990 Dec 01; 21(6):259-67. PubMed ID: 1980385
    [Abstract] [Full Text] [Related]

  • 25. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M, Damjanović A, Jovanović A, Cvetić T, Jasović-Gasić M.
    Psychiatr Danub; 2009 Jun 01; 21(2):187-93. PubMed ID: 19556947
    [Abstract] [Full Text] [Related]

  • 26. Can nonantidepressants help treat depression?
    Chilakamarri G, Weismantel D, Weismantel A.
    J Fam Pract; 2009 Oct 01; 58(10):550-1. PubMed ID: 19874735
    [No Abstract] [Full Text] [Related]

  • 27. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
    Tsai AC.
    J Clin Psychopharmacol; 2009 Feb 01; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
    [No Abstract] [Full Text] [Related]

  • 28. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.
    Nelson JC, Baumann P, Delucchi K, Joffe R, Katona C.
    J Affect Disord; 2014 Oct 01; 168():269-75. PubMed ID: 25069082
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis.
    Papakostas GI, Salloum NC, Hock RS, Jha MK, Murrough JW, Mathew SJ, Iosifescu DV, Fava M.
    J Clin Psychiatry; 2020 May 26; 81(4):. PubMed ID: 32459407
    [Abstract] [Full Text] [Related]

  • 30. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.
    Hamoda HM, Osser DN.
    Harv Rev Psychiatry; 2008 May 26; 16(4):235-47. PubMed ID: 18661366
    [Abstract] [Full Text] [Related]

  • 31. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.
    Papakostas GI, Shelton RC, Smith J, Fava M.
    J Clin Psychiatry; 2007 Jun 26; 68(6):826-31. PubMed ID: 17592905
    [Abstract] [Full Text] [Related]

  • 32. [Recent advances in clinical psychopharmacology].
    Mori A.
    Yakubutsu Seishin Kodo; 1984 Nov 26; 4(3):201-12. PubMed ID: 6152505
    [Abstract] [Full Text] [Related]

  • 33. Psychotic major depression: a benefit-risk assessment of treatment options.
    Tyrka AR, Price LH, Mello MF, Mello AF, Carpenter LL.
    Drug Saf; 2006 Nov 26; 29(6):491-508. PubMed ID: 16752932
    [Abstract] [Full Text] [Related]

  • 34. [Antidepressants, antipsychotics and metabolic risks].
    Wittmann M, Hübner-Liebermann B, Wenzel-Seifert K, Hausner H.
    MMW Fortschr Med; 2011 Mar 03; 153(9):42-4. PubMed ID: 21638864
    [No Abstract] [Full Text] [Related]

  • 35. What is the role of conventional antidepressants in the treatment of major depressive episodes with Mixed Features Specifier?
    Faedda GL, Marangoni C.
    CNS Spectr; 2017 Apr 03; 22(2):120-125. PubMed ID: 27831463
    [Abstract] [Full Text] [Related]

  • 36. Adverse Effects of Second-Generation Antipsychotics as Adjuncts to Antidepressants: Are the Risks Worth the Benefits?
    Thase ME.
    Psychiatr Clin North Am; 2016 Sep 03; 39(3):477-86. PubMed ID: 27514300
    [Abstract] [Full Text] [Related]

  • 37. [Psychopharmacology of anxiety and depression: Historical aspects, current treatments and perspectives].
    Javelot H.
    Ann Pharm Fr; 2016 Mar 03; 74(2):93-118. PubMed ID: 26472602
    [Abstract] [Full Text] [Related]

  • 38. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
    McIntyre RS, Muzina DJ, Adams A, Lourenco MT, Law CW, Soczynska JK, Woldeyohannes HO, Nathanson J, Kennedy SH.
    Expert Opin Pharmacother; 2009 Dec 03; 10(18):3061-75. PubMed ID: 19954275
    [Abstract] [Full Text] [Related]

  • 39. Letter to the editor: Are ketamine-induced subjective bodily experiences associated with antidepressant effects? A sensation of floating and a sensation of lightness are not the same - A comment on Acevedo-Diaz et al.
    Stocker K, Hasler G, Hartmann M.
    J Psychiatr Res; 2021 May 03; 137():454-455. PubMed ID: 33798971
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy and tolerability of treatments for bipolar depression.
    Vázquez GH, Holtzman JN, Tondo L, Baldessarini RJ.
    J Affect Disord; 2015 Sep 01; 183():258-62. PubMed ID: 26042634
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.